Lash Serums: Conditioning Cosmetic Versus Growth Drug

Two lash serums can have nearly identical formulas and land in completely different regulatory categories, because the thing that decides it isn't the ingredient list. It's the claim on the bottle.

The line that actually matters

A serum marketed to condition, moisturize, or make lashes appear fuller and healthier through cosmetic means, coating, strengthening the visible hair shaft, adding shine, stays in cosmetic territory. A serum marketed to make lashes actually grow longer, thicker, or in greater number, implying it changes the biological growth process itself, is making a claim that reads as a drug claim, because it's asserting an effect on the structure or function of the body rather than just cleansing, beautifying, or altering appearance superficially.

This is the same basic distinction that separates any cosmetic from a drug generally: sunscreen, anti-acne, anti-dandruff, antiperspirant, and fluoride toothpaste are treated as drugs because they claim to affect a body function or treat a condition, not just alter appearance. Lash and brow serums sit right at that boundary more than almost any other product category, because "growth" is such a central part of how the category is marketed.

Why this catches indie brands off guard

A lot of lash serum formulas include peptides, biotin, panthenol, and various conditioning agents that genuinely do make lashes look and feel healthier, which makes it tempting to describe the product in growth language because that's how the whole category talks about itself online. But regulatory classification doesn't care how the competitive landscape talks. It cares what your specific label and marketing claim.

"Lashes appear longer and fuller" is doing careful work: it's describing a cosmetic effect (appearance) rather than asserting the lash itself is growing longer. "Clinically proven to grow lashes up to 25% longer" is a completely different claim, asserting an actual physiological growth effect, and that kind of claim is the sort of thing that has drawn regulatory attention to serums in this category before.

A side-by-side on common claim language

Claim type	Example wording	Likely classification
Conditioning	"Nourishes and conditions lashes for a healthier look"	Cosmetic
Appearance	"Lashes appear fuller and more defined"	Cosmetic
Structural strengthening	"Strengthens the lash to reduce breakage"	Generally cosmetic, worded carefully
Growth/length claim	"Promotes lash growth" or "grows longer lashes"	Drug territory
Follicle/biological claim	"Stimulates the follicle for new lash growth"	Clearly drug territory

The middle rows are where careful wording earns its keep. "Reduces the appearance of breakage" and "helps lashes look stronger" stay on the cosmetic side. "Reduces breakage so lashes grow longer" starts leaning toward asserting a growth mechanism, which is a harder claim to defend as purely cosmetic.

What to actually check before you launch

1. Read your own product description, bottle copy, and any marketing material as if you were a skeptical regulator, not as the founder who knows what you meant.
2. Flag any word implying growth, length increase, follicle stimulation, or a biological mechanism, and rewrite it around appearance and conditioning instead if you want to stay cosmetic.
3. If your formula includes an ingredient specifically known for growth-stimulating pharmacological activity, that's a formulation question worth resolving before the claims question, since the ingredient itself might push you toward drug classification regardless of how you word the label.
4. Keep your internal safety and claims substantiation file consistent with the toned-down cosmetic language you actually put on the label. A mismatch between internal marketing plans and public label claims is its own kind of risk.

Filing it as a cosmetic

Assuming your claims genuinely stay on the conditioning and appearance side, a lash or brow serum sold in Canada still needs the standard Cosmetic Notification Form filing within 10 days of first sale, with every active ingredient listed by INCI name and concentration, including any peptide complexes or supplier blends broken into their real components.

Getting the ingredient list right on a serum like this often means chasing down peptide blend documentation from suppliers who are used to talking in trade names rather than INCI, which is fiddly work. Cosmetic Comply handles exactly that expansion, mapping trade names to INCI and carrying blend percentages through to the finished product concentration, then screens the result against restricted ingredient lists before a human reviewer signs off.

Get the claim wording right first, though. No amount of correct ingredient filing changes a product's category if the label itself is asserting a growth effect that belongs to drug review instead.